Clinical Trial Update: Clinical Study of R744 to Hemodialysis Patients [Phase 3]

View source ↗

Summary

Phase 3 trial of R744 in patients undergoing hemodialysis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• R744

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Hemodialysis Patients | Phase 3 | Status: COMPLETED